A Comparative Analysis of Multiple Myeloma Disease Burden in China and Globally From 1990 to 2023 and Future Trend Projections

Abstract

Multiple myeloma (MM) is a prevalent hematologic malignancy. A systematic comparison of the temporal trends in MM disease burden between China and the global level is important for optimizing prevention and control strategies. This study describes trends in the age‐ and sex‐specific burden of MM in China from 1990 to 2023, including incidence, prevalence, mortality, and disability‐adjusted life years (DALYs); projects sex‐specific incidence to 2050; and compares findings globally.